Federal Register Notice: FDA is canceling the meeting of the Peripheral and Central Nervous System Drugs Advisory Committee scheduled for 5/16 due to scheduling difficulties, according to an Eisai Medical spokeswoman. The company’s sNDA for Aricept, indicated for the treatment of vascular dementia, was on tap for discussion. To view this notice, click here.